Abstract:Neuroinflammation, characterized by activation of glial cells, plays a critical role in central nervous system disorders. However, the precise mechanisms of neuroinflammation contributing to cognitive impairment remain elusive. Perineuronal nets (PNNs) are extracellular matrixes that envelop the cell bodies and dendrites of parvalbumin (PV)-positive interneurons and may be mediated by apolipoprotein E (ApoE) gene. To investigate whether disruption of PNNs associated with ApoE is implicated in neuroinflammation-induced cognitive impairment, we established a neuroinflammation model by administering lipopolysaccharides (LPS) at 0.5 mg/kg for 7 consecutive days. Cognitive function was assessed using the open field, Y-maze, and novel object recognition tests, and neural oscillations were also recorded. Furthermore, differentially expressed genes in microglia within the hippocampus were identified through single-cell RNA sequencing analysis. Overexpression of hyaluronan and proteoglycan link protein 1 (Hapln1) and ApoE knockdown were carried out through adeno-associated virus (AAV) injection to C57BL/6J mice and CX3CR1-CreERT2 mice, respectively. It was found that LPS-induced neuroinflammation impaired cognitive function by reducing PNNs and PV-positive interneurons' outputs, as well as disrupting gamma (γ) oscillations in the hippocampal CA1. Overexpression of Hapln1 was able to restore PV-positive interneurons and γ oscillations, ultimately alleviating the cognitive impairment. Mechanistically, LPS-triggered microglial activation leads to the phagocytosis of PNNs, a process influenced by ApoE. Notably, prevention of PNNs engulfment through targeting microglial ApoE in the CA1 improved cognitive impairment. Collectively, our study suggested that microglial phagocytosis of PNNs plays a key role in neuroinflammation-induced cognitive impairment, which is probably mediated by the ApoE.

Epigenetic suppression of neuroligin 1 underlies amyloid-induced memory deficiency

Epigenetic Suppression of Hippocampal BDNF Mediates the Memory Deficiency Induced by Amyloid Fibrils

Calmodulin Shuttling Mediates Cytonuclear Signaling to Trigger Experience-Dependent Transcription and Memory

Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency

Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid plaques

Chronic IL-1-induced DNA double-strand break response in hippocampal neurons drives cognitive deficits

Increased EID1 nuclear translocation impairs synaptic plasticity and memory function associated with pathogenesis of Alzheimer's disease

Epigenetic derepression of H3K9me3 mitigates Alzheimer-related pathology and improves cognition via immunomodulation and Vgf induction

Concerted Cellular Responses to Type I Interferon Propel Memory Impairment Associated with Amyloid Β Plaques

Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease

Microglia CREB-Phosphorylation Mediates Amyloid-β-Induced Neuronal Toxicity.

Overexpression of endophilin A1 exacerbates synaptic alterations in a mouse model of Alzheimer’s disease

Microglia Phagocytosis of PNNs Mediates PV-positive Interneuron Dysfunction and Associated Gamma Oscillations in Neuroinflammation-Induced Cognitive Impairment in Mice

Inhibition of EHMT1/2 rescues synaptic damage and motor impairment in a PD mouse model

Activity-induced histone modifications govern Neurexin-1 mRNA splicing and memory preservation

Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory

GABAergic Neuronal IL-4R Mediates T Cell Effect on Memory

Epigenetic regulation of reelin and brain-derived neurotrophic factor genes in long-term potentiation in rat medial prefrontal cortex

Endoplasmic Reticulum Chaperone Genes Encode Effectors of Long-Term Memory

P2–017: Inhibition of Protein Phosphatases Induces Impairment in Axonal Transport and Spatial Memory Retention

N-myc downstream-regulated gene 2 deficiency aggravates memory impairment in Alzheimer's disease